Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
6.21
+0.35 (5.97%)
At close: Jul 2, 2026, 4:00 PM EDT
6.09
-0.12 (-1.93%)
After-hours: Jul 2, 2026, 7:59 PM EDT
Aspire Biopharma Holdings Revenue
Aspire Biopharma Holdings had revenue of $28.35K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $34.56K. In the year 2025, Aspire Biopharma Holdings had annual revenue of $6.20K.
Revenue (ttm)
$34.56K
Revenue Growth
n/a
P/S Ratio
232.77
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.20K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionASBP News
- 10 days ago - Aspire Biopharma's BUZZ BOMB(TM) Launches on Amazon, Introducing Next-Generation Caffeine Stick Packs - Accesswire
- 17 days ago - Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th - GlobeNewsWire
- 22 days ago - Aspire Biopharma Holdings Inc trading resumes - TheFly
- 22 days ago - Aspire Biopharma Holdings Inc trading halted, volatility trading pause - TheFly
- 22 days ago - Aspire Biopharma signs definitive SPA to acquire Dura Driver Control Systems - TheFly
- 22 days ago - Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue - Accesswire
- 5 weeks ago - Aspire Biopharma issues letter to shareholders - TheFly
- 5 weeks ago - Aspire Biopharma Issues Shareholder Letter - Accesswire